GlassScriptPhysician profile
Chad Brashear
NPI 1730365305
$9,341.86
in general payments reported to CMS, 2019-2025
35 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $861 · 2021: $5,012 · 2022: $672 · 2023: $1,443 · 2024: $348 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.45 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,800.07 | 2020-2023 | Davinci Xi |
| Davol INC. | $1,735.17 | 2019-2024 | Capsure Permanent Fixation System, Phasix Mesh, Ventralight St |
| Smith+Nephew, INC. | $295.23 | 2019-2024 | Collagenase Santyl, Regranex, Stravix |
| Covidien LP | $210.16 | 2019-2020 | |
| Medical Device Business Services, INC. | $194.38 | 2019 | |
| Kerecis Limited | $138.80 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Reprise Biomedical, INC. | $79.65 | 2021-2025 | Miro3d, Miro 3d |
| Medtronic, INC. | $71.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.37 | 2021-2025 | Gattex |
| Organogenesis INC. | $62.36 | 2025 | Puraply Wound Matrix, Apligraf |
| Boston Scientific Corporation | $55.42 | 2022-2023 | Spaceoar Vue System - 10ml, Spyglass Discover |
| W. L. Gore & Associates, INC. | $50.26 | 2023 | Gore Synecor Biomaterial |
| Asensus Surgical, INC. | $48.12 | 2019 | |
| Misonix INC | $41.47 | 2019 | |
| Teleflex LLC | $38.76 | 2019-2025 | Titan Sgs Bailout Chuck |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $37.96 | 2021-2023 | Zynrelef |
| La Jolla Pharmaceutical Company | $37.60 | 2023 | Xerava |
| Axonics, INC. | $35.82 | 2023-2024 | Axonics |
| Pacira Pharmaceuticals Incorporated | $29.09 | 2019-2024 | Exparel |
| Osiris Therapeutics INC. | $28.48 | 2019 | |
| Melinta Therapeutics, LLC | $24.93 | 2019 | |
| Polynovo North America LLC | $23.65 | 2024 | Novosorb Btm |
| Solventum Corporation | $23.62 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Acacia Pharma INC | $22.67 | 2022 | |
| Hologic Sales and Service, LLC | $22.29 | 2024 | Localizer |
| Reapplix INC. | $21.94 | 2025 | 3c Patch Kit - Box |
| Eagle Pharmaceuticals, INC. | $20.71 | 2024 | |
| Ambu INC. | $20.00 | 2023 | |
| Baxter Healthcare | $19.69 | 2021 | |
| Biotissue Holdings INC. | $18.16 | 2024 | |
| Tela Bio, INC. | $15.85 | 2021 | |
| Innocoll Pharmaceuticals Limited | $15.85 | 2022 | |
| Endogastric Solutions, INC | $14.00 | 2023 | Esophyx |
| Integra Lifesciences Corporation | $12.76 | 2022 | |
| Clinical Technology, INC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Brashear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.